| Pharmaceutical active ingredients: |
| Ambroxol Hydrochloride |
| Available forms, composition and doses of Bronchopront: |
| Capsules, Retard; Oral; Ambroxol HydrochlorideDrops; Oral; Ambroxol HydrochlorideSuspension; Oral; Ambroxol Hydrochloride 15 mg / 5 mlSyrup; Oral; Ambroxol Hydrochloride 15 mg / 5 ml |
| Bronchopront medical category: |
| Human:Cough and cold preparations |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R05CB06 - Ambroxol |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| PfizerCombipharEdward KellerFerraz LynceGrunenthalHeinrich Mack NachfolgerKeri PharmaSummitZuellig Pharma |